Rocket Lab (NASDAQ:RKLB) Stock Price Down 4.6% – Here’s What Happened

Rocket Lab Corporation (NASDAQ:RKLB)’s share price traded down 4.6% during trading on Friday . The stock traded as low as $63.50 and last traded at $64.39. Approximately 18,410,396 shares changed hands during trading, a decline of 22% from the average session volume of 23,475,879 shares. The stock had previously closed at $67.53.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Launch and defense businesses continue to build momentum. Rocket Lab has reached 93 Electron launches, while its HASTE hypersonic test vehicle is supporting Pentagon missions. The company’s expanding defense portfolio could provide recurring revenue and diversify it beyond commercial launch services. Rocket Lab’s HASTE Is Flying Hypersonic Missions for the Pentagon
• Positive Sentiment: Analysts see potential for a rebound. A hammer chart pattern has suggested possible technical support, while analysts have revised earnings expectations higher. Rocket Lab’s reported consensus rating remains “Moderate Buy,” with an average price target of $110.65, although that view depends on substantial future execution. Why Rocket Lab Could Be a Bottom-Fishing Opportunity
• Neutral Sentiment: Iridium shareholders are preparing to vote on the proposed transaction. The vote represents a key milestone for Rocket Lab’s pending approximately $8 billion acquisition, but final approval and closing remain subject to shareholder and regulatory processes. Iridium Sets Shareholder Vote on Rocket Lab Acquisition
• Negative Sentiment: SpaceX has raised a regulatory risk around the Iridium deal. In comments to the Federal Communications Commission, SpaceX said alleged anticompetitive conduct by Iridium “hangs as a cloud” over the transaction. SpaceX does not formally oppose the deal, but the filing could lead to additional scrutiny, delays or conditions—making the acquisition harder to value. SpaceX Flags Iridium Deal to the FCC
• Negative Sentiment: Neutron remains the largest execution risk. Investors are increasingly focused on reports that the medium-lift rocket’s debut could slip into 2027. A delay would postpone a major growth catalyst and extend development spending, while much of Rocket Lab’s current revenue still comes from satellites and space systems. Rocket Lab’s Neutron Timeline Remains a Key Risk
• Negative Sentiment: Profitability and valuation concerns remain. Rocket Lab’s latest quarterly revenue exceeded estimates, but its loss per share was wider than expected, and analysts still expect a full-year loss. With a roughly $38 billion market value and a high-beta stock profile, investors have little tolerance for delays or weaker growth.
• Negative Sentiment: Multiple insider sales have added pressure. Executives sold approximately $5.5 million of shares, including transactions by the CFO and COO. The sales were made under pre-arranged Rule 10b5-1 plans to cover tax withholding, reducing their significance, but the lack of insider buying may still weigh on sentiment.

Analysts Set New Price Targets

Several research analysts have recently commented on RKLB shares. Roth Capital set a $110.00 price objective on Rocket Lab in a report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rocket Lab in a research report on Friday, July 17th. KeyCorp restated an “overweight” rating on shares of Rocket Lab in a research report on Tuesday, August 11th. BTIG Research restated a “hold” rating on shares of Rocket Lab in a research note on Tuesday, May 12th. Finally, Stifel Nicolaus set a $132.00 target price on shares of Rocket Lab in a research note on Thursday, June 4th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $110.65.

Rocket Lab Stock Performance

The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The company has a market capitalization of $38.53 billion, a P/E ratio of -238.47 and a beta of 2.60. The business’s fifty day simple moving average is $78.66 and its 200-day simple moving average is $85.12.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million for the quarter, compared to analysts’ expectations of $231.62 million. As a group, equities analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Insider Buying and Selling at Rocket Lab

In related news, SVP Arjun Kampani sold 7,754 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $539,911.02. Following the sale, the senior vice president directly owned 256,951 shares of the company’s stock, valued at $17,891,498.13. This represents a 2.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Bradford Clevenger sold 15,051 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the sale, the insider directly owned 458,924 shares of the company’s stock, valued at $31,954,878.12. This represents a 3.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 3,482,622 shares of company stock valued at $306,340,164. Corporate insiders own 8.40% of the company’s stock.

Hedge Funds Weigh In On Rocket Lab

Hedge funds have recently added to or reduced their stakes in the stock. Mcguire Capital Advisors Inc. purchased a new position in Rocket Lab during the 4th quarter worth $27,000. Zions Bancorporation National Association UT purchased a new position in shares of Rocket Lab in the 4th quarter worth approximately $28,000. EverSource Wealth Advisors LLC raised its stake in shares of Rocket Lab by 109.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer’s stock worth $28,000 after acquiring an additional 416 shares in the last quarter. Gordian Capital Singapore Pte Ltd purchased a new stake in Rocket Lab during the fourth quarter valued at approximately $29,000. Finally, Reflection Asset Management acquired a new stake in Rocket Lab in the fourth quarter valued at approximately $30,000. 71.78% of the stock is currently owned by institutional investors.

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.